AL Amyloidosis - 146 Studies Found
| Completed |
: Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma : 2008-11-12 :
|
| Active, not recruiting |
: Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis : Primary Amyloidosis : 2012-10-11 : Drug: NEOD001 Monoclonal antibody administered by intravenous infusion every 28 days. |
| Active, not recruiting |
: S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis :
: 2003-07-08 :
|
| Recruiting |
: Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial : Primary Systemic Amyloidosis : 2014-07-23 : Drug: Doxycycline Doxycycline will be continued until one |
| Completed |
: Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis :
|
| Active, not recruiting |
: A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis :
: 2013-02-06 :
|
| Completed |
: 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma and Plasma Cell Neoplasm : 1999-11-01 : Drug: 4'-iodo-4'-deoxydoxorubicin |
| Completed |
: Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma and Plasma Cell Neoplasm : 2007-11-28 :
|
| Completed |
: High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma and Plasma Cell Neoplasm : 1999-11-01 :
|
| Completed |
: Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis : Multiple Myeloma and Plasma Cell Neoplasm : 2004-08-04 :
|